![]() |
|
|


2
Faculty of Medicine, Departments of
*
Pharmacology and Clinical Pharmacology,
Biophysics, Sihhiye 06100, Ankara University, Ankara, Turkey
2To whom correspondence should be addressed.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: trace element selenium vitamin E receptor-adenylate cyclase coupling rat cardiac myoctes
| INTRODUCTION |
|---|
|
|
|---|
Chronic Se toxicity affects the major organs including liver, spleen,
kidney and heart in experimental animals; especially sodium selenite
has been shown to cause cellular dysfunction in a number of cells and
tissues including erythrocytes (Young et al. 1981
),
hepatocytes (Anundi et al. 1982
), lens
(Hightower and McCready 1991
, Wang et al.
1993), skeletal muscle (>Lin-Shiau et al. 1989
)
and heart muscle (Turan et al. 1996
). Selenium toxicity
in humans is rare, yet it occurs with symptoms similar to those in
animals (Yang et al. 1983
).
The mechanism of Se toxicity, as well as its deficiency, is not clearly
understood. The toxicity of Se likely is related to its ability to form
covalent linkages with intracellular proteins (Dickson and Tappel 1969
). Selenite catalyzes oxidation of glutathione
(Tsen and Tappel 1958
) and can react intracellularly
with other sulfhydryl compounds (Björnstedt et al. 1992
, Frenkel et al. 1991
, Handel et al. 1995
, Yang and Yang 1989
). On the
other hand, most pathologies associated with Se deficiency appear to be
directly attributable to increased free-radical damage in tissues
(Bettger 1993
, Burk 1989
and
1990
, Hoekstra 1975
, Levander 1986
, Sunde 1990).
In earlier studies, it was pointed out that Se and vitamin E are
nutrients which are interrelated in their metabolic functions
(Schwarz 1965
, Tappel 1965
). Se
deficiency alone did not affect the electrophysiological or mechanical
functions of rat hearts (Ringstad et al. 1988
,
Ytreus et al. 1988
), whereas the combined deficiency of
Se and vitamin E leads to some abnormalities in cardiovascular
functions of both humans and laboratory animals (Chen et al. 1980
, Grupp et al. 1983
, Oldfield 1987
, Olson and Kobayoshi 1992
,
Shamberger 1983
). In a recent study, using electrically
stimulated papillary muscles isolated from rats fed with a Se and
vitamin E-deficient diet, we demonstrated that isoproterenol
(ISO)-induced facilitation of muscle contraction was smaller than that
observed in muscles from control animals. A similar decrease in
ß-adrenergic response was also observed in rats fed with a Se excess
diet (Turan et al. 1999
).
In the present study, to further investigate the effects of combined Se and vitamin E deficiency or Se excess on ß-adrenergic responses in cardiac cells, we fed one group of rats with a combined Se and vitamin E-deficient diet (deficient group) and another with a diet containing excess Se (excess group). In these groups, we investigated molecular mechanisms that may underlie the changes in responsiveness of cardiac muscle to adrenergic stimulation. We used whole-cell patch-clamp technique to study the L-type Ca2+ current in isolated cardiac myocytes (a slow inward Ca2+ current, ICa,L, which is characterized by activation at relatively more depolarized potentials and is the dominant Ca2+ current in all mature cardiac myocytes from rats). Also the modulation of this ICa,L by ß-adrenergic stimulation was studied. We additionally used some biochemical techniques to obtain information about the state of coupling between ß-adrenoceptors and adenylate cyclase, and the receptor density in cardiomyocytes.
| METHODS |
|---|
|
|
|---|
Weanling Wistar rats (Ankara University Medical Faculty, Animal Care Facility) of either sex were divided randomly into three groups and housed in stainless steel, wire-bottomed cages initially at a density of three per cage and as they grew, were then caged individually. They were maintained at an ambient air temperature of 22 ± 1°C and a 12-h light/dark cycle. All procedures used in the experiments were approved by the Ethics Committee of Ankara University Medical School.
Diets and feeding.
The deficient diet was obtained commercially. The basal diet was a Se-
and vitamin E-deficient torula yeast-based diet. It contained
30% torula yeast, 0.3% DL-methionine, 58.7% sucrose, 2%
corn oil, 5% Se-deficient AIN-76 TM mineral mix, 1% vitamin
E-deficient vitamin mix AIN-76 TM (Horland Tekland, Madison, WI;
Koukay et al. 1990
). Se and vitamin E were supplemented
in adequate and rich diets with sodium selenite and
-tocopherol
acetate (Sigma). Selenium content of the diets was determined by using
a graphite furnace atomic absorption spectrometer (Varian Atomic
Absorption Spectrometer AA-30/40, Sydney, Australia). Based on
analysis of random batches of diet, Se concentration of the deficient
diet was 9.8 µg Se/kg, and the adequate and rich diets contained 225
µg Se/kg-diet and 4.2 mg Se/kg, respectively. Deionized water was
given to the rats, which contained very little Se (<1 µg/L). The
rats were fed either an adequate diet (control group), a deficient diet
(Se- and vitamin E-deficient group) or an excess diet (Se-excess
group). The rats were permitted free access to the food and water for
1214 wk.
Tissue preparation and analysis for Se levels.
Rats were anesthetized with a mixture of sodium pentobarbital (30
mg/kg) and heparin. Blood samples for Se and vitamin E determinations
were collected by cardiac puncture. The thorax was opened and hearts
were removed for determinations of Se levels. Plasma vitamin E
concentrations were determined by HPLC (McMurray and Blanchflower 1979
). Se levels were measured using a Zeeman
graphite furnace atomic absorption spectrometer (AA-30/40 Varian
Spectrophotometer) (Berly and Gillian 1988
). As reported
previously (Turan et al. 1999
), Se concentrations in
plasma, erythrocytes and heart homogenates (as mean ± SD) were 4.21 ± 1.16 µmol/L, 11.06 ± 1.08
nmol/g hemoglobin and 4.83 ± 0.15 nmol/g wet weight,
respectively, in the control group; 2.16 ± 1.13 µmol/L, 4.11
± 0.34 nmol/g hemoglobin and 1.90 ± 0.11 nmol/g wet weight,
respectively, in the deficient group; 11.91 ± 1.08 µmol/L, 17.5
± 1.31 nmol/g hemoglobin, and 16.03 ± 0.60 nmol/g wet
weight, respectively, in the excess group. Plasma vitamin E levels in
deficient rats were 50% of the control animals.
Isolation of ventricular myocytes.
Myocytes were isolated according to the method of Wittenberg et al. (1986)
. Briefly, hearts were perfused at 37°C with a
HEPES-buffered solution containing (in mmol/L): NaCl 123, KCl 5.4,
NaHCO3 5,
NaH2PO4 2,
MgCl2 1.6, glucose 10, taurine 20, HEPES 20, pH
7.1 and bubbled with 100% O2. After 5 min,
hearts were perfused with the same buffer containing 0.81.5 g/L
collagenase with a perfusion rate of 810 mL/min for 1030 min. At
the end of the collagenase perfusion, a piece of left ventricle was cut
off and stirred to obtain cells. The cells were then suspended at
37°C in the HEPES-buffered solution containing 1 mmol/L
CaCl2 and 0.5% bovine serum albumin. The
myocytes were kept under this condition and used in experiments within
46 h. Generally 57 x 106 cells were obtained
from control rats. Usually 7080% of these cells were well relaxed as
assessed by microscopic inspection. Cell yields from both of the
altered diet groups were much lower than the control group.
Recording of Ca2+ currents from whole-cell patch clamp.
To record Ca2+ current
(ICa,L), the ventricular myocytes were placed in
a tissue culture dish and superfused by gravity with a solution
containing (in mmol/L): CsCl 20, NaCl 117, CaCl2
1.8, MgCl2 1.7, glucose 10 and HEPES 10, pH 7.4.
The current recordings were performed under the presence of
tetrodotoxin (50 µmol/L) and cesium in the superfusing solution to
inhibit the Na+ and K+
currents, respectively. The internal solution in the patch electrode
(resistance of 1.53.5 M
) contained (in mmol/L): CsCl 120,
MgCl2 6.8, Na2ATP 5,
Na2-creatine phosphate 5,
Na2GTP 0.4, EGTA 5, CaCl2
0.06 and HEPES 20, pH adjusted to 7.2 with CsOH. Once a cell was sealed
to the electrode, it was lifted up and exposed to different
extracellular solutions, containing different concentrations of ISO (in
the range of 0.1 nmol/L to 1 µmol/L), by positioning the pipette at
the extremity of one of the six capillaries flowing at a steady rate.
Experiments were carried out at room temperature (22 ± 1°C).
Whole cell currents (ICa) were recorded using a
RK-300 (Biologic, Grenoble, France) patch-clamp amplifier. For the
recording and analysis of the currents, we used a homemade data
acquisition program written in Pascal, called PCSoft. To monitor
ICa, ventricular myocytes were depolarized from
-70 mV holding potential to 0 mV for 200 ms every 4 s. Current
recordings were filtered at 1 kHz and sampled at a rate of 10 kHz
(12-bit A/D converter, Advantech PCL-818PG; Advantech Co., Taipen,
Taiwan). ICa amplitude was measured as the difference
between peak inward current and the current at the end of 200 ms
voltage pulse. Rundown of peak ICa was limited, generally
to 10% within 30 min. The fast and slow inactivation constants of
ICa were calculated by fitting the data to a sum of two
exponential functions by a homemade program using a simplex algorithm.
This homemade data acquisition system monitors continuously the series
resistance (Rs), the membrane resistance (Rm)
and the membrane capacitance (Cm). This system has also an
advantage to stop current recording to avoid acquisition of data when
the Rs > 10 M
, which can be misleading due to the
high series resistance. In our study, the Rs ranged from 4
to 9 M
. The series resistance and the membrane capacitance were not
compensated during current recordings.
Membrane preparation.
Crude myocardial membranes were prepared from control, Se-deficient and Se-excess groups (n = 7, 7 and 9, respectively) by homogenizing whole hearts (using Ultraturax with 3 x 20 s bursts at maximum speed) in ice-cold lysis buffer (10 mmol/L Tris-HCl, pH 7.4, 1mmol/L EDTA, 0.2 mmol/L phenylmethylsulphonylfloride, aprotinin 5 mg/L). The homogenate was centrifuged at 500 x g for 15 min, and the supernatant was used to obtain membrane pellet following a centrifugation at 45,000 x g for 30 min. Membranes were washed twice with buffer (50 mmol/L Tris-HCl pH: 7.4, 10 mmol/L MgCl2, 1 mmol/L EDTA, 2 mmol/L dithiothreitol, 0.2 mmol/L phenylmethylsulphonylfloride, aprotinin 5 mg/L) and stored (3 g/L of protein) in the same buffer including 25% sucrose at 45°C until assayed for receptor binding, adenylate cyclase activity or Western blotting.
Binding experiments.
Competition binding of [125I]-iodopindolol
([125I]-IPIN, 80 pmol/L) (synthesized by using
chloaramine T method and purified on reverse-phase HPLC to a
specific activity of 7400 x 1010 Bq/mmol)
(Barovsky and Brooker 1980
, Wolf and Harden 1981
) with isoproterenol in the presence or absence of
5'guanylyimidodiphosphate (GppNHp) was measured in triplicate after
equilibrating the binding reaction (40 µg membrane protein) in
binding buffer for 60 min at 37°C (50 mmol/L TRIS at pH 7.4 and 100
mmol/L KCl) in a total volume of 100 µL. Reactions were terminated by
adding 3 mL of ice-cold binding buffer and rapid filtration through
Whatman GF/B filters using a vacuum filtration manifold (Millipore,
Bedford, MA). Filters were washed twice with 4 mL of ice-cold
binding buffer and counted for radioactivity.
In order to measure ß-adrenoceptor density in the heart membranes, single concentration of [125I] IPIN was used at a concentration of 800 pmol/L (80 times of its Kd value) to saturate ß-adrenoceptors. Nonspecific binding was determined in the presence of 100 µmol/L of unlabeled propranolol and specific binding was calculated as the difference between total and nonspecific bindings.
Adenylate cyclase assay.
Adenylate cyclase assay was performed using 5 µg membrane protein in
a total volume of 100 µL in triplicate or quadruplicate as described
previously (Ugur and Onaran 1997
). Briefly the assay was
started by adding cyclase buffer (final: 50 mmol/L Tris, pH 7.4, 100
mmol/L KCl, 1.6 mmol/L MgCl2, 0.5 mmol/L ATP, 1
mmol/L isobutylmethylxanthine, 5 mmol/L phosphoenolpyruvate and 5 x 103 U/mL pyruvate kinase) onto the membranes
that were equilibrated for 5 min with various stimuli at 37°C. The
reaction was stopped after 10 min by adding 100 µL of 0.2 mol/L HCl.
Accumulated cyclic AMP (cAMP) was measured by radioimmunoassay using
acetylation protocol. Accumulation of cAMP per mg membrane protein per
minute was considered as adenylate cyclase activity.
Immunoblotting.
The expression level of Gs
protein in the membranes was assessed by
Western blotting. SDS-PAGE (%10) was performed according to the
method of Laemmli (1970)
. We used anti-Gs
primary antibody (RM/1;
New England Nuclear, Boston, MA) to label Gs
on the blotting
membrane and visualized the antibody-bound Gs
by using ECL
(Amersham). Protein concentration in the membrane preparations was
determined according to the Bradford method (Bradford 1976
).
Statistical analysis.
All data are reported as mean ± SEM. Students t test was used for the comparison of means. Probability values < 0.05 were considered significant.
| RESULTS |
|---|
|
|
|---|
Voltage dependence of the L-type calcium current
(ICa,L) recorded from isolated cardiac cells were
different in Se-excess and Se-deficient diet groups when
compared to the control group. For both experimental groups, threshold
potential for activation was significantly lower than the control group
(P < 0.05), and potential for maximum activation was
higher than the control group (P < 0.05) but the
maximum current value was not different (Fig. 1
, Table 1
).
|
|
At most, three cumulative doses of ISO were used for lower
concentrations (from 0.1 to 10 nmol/L). Noncumulative doses were used
for higher concentrations to avoid desensitization. In control cells, 1
µmol/L ISO caused a 90 ± 3.3% maximal increase in
ICa over its baseline value (Fig. 2
). Meanwhile deficient and excess groups showed a maximal increase of
only 20 ± 3.4 and 30 ± 3.6%, respectively. These two
values were significantly less than the control values (P
< 0.001). However, the EC50 values,
calculated from dose-response curves shown in Figure 2
, were not
different among groups (30, 34 and 32 nmol/L in control, deficient and
excess groups cells, respectively).
|
In heart cells from both experimental groups, time to peak
(Tp) and two inactivation time constants
(
s "slow" and
f
"fast") for ICa (estimated from the current
induced by the voltage pulse from 70 to 0 mV for 200 ms) were all
significantly less than the control group values (P < 0.01), but were not different from each other (Table 2
, see also Fig. 2
upper panel). In any group, 1 µmol/L ISO did not
alter Tp,
s and
f values significantly (Table 2)
.
|
Basal cyclase activity and cyclase activity induced by several stimuli
are shown in Figure 3
. To eliminate interday variations from the data and make the results
easier to interpret, cyclase activity is given, for each stimulus, as
the difference between experimental and control groups, normalized to
the actual activity of the control (values from the control group are
measured on the same day and in parallel to the other two groups).
|
Binding experiments.
Saturation binding experiments were performed in these membranes to determine the total ß-adrenoceptor number. We also investigated the GppNHp-induced shift in agonist affinity (in agonist competition experiments) as a measure of the efficiency of receptor-G-protein coupling.
Saturation binding experiments showed no significant difference in the number of [125I] IPIN binding sites between control and excess group membranes (36.36 ± 3.15 and 40.75 ± 3.84 fmol/mg protein, respectively), but binding sites were significantly lower in the deficient group (27.29 ± 3.01 fmol/mg protein) compared to the control (%73 of control membranes) (P < 0.05).
In agonist competition experiments, in all groups, agonist affinity
measured in the presence of GppNHp (10 µmol/L) did not differ among
control, deficient and excess groups. However, GppNHp induced a
significant shift in agonist IC50 in the control
and Se excess groups, but not in the Se-deficient group (calculated using ALFIT by using extra sum of squares principle; De Lean et al. 1978
) (see Fig. 4
). Shifts in log IC50 values were as follows:
1.000 ± 0.224 (P < 0.001), 0.400 ± 0.245
(P = 0.12) and 0.600 ± 0.212 (P = 0.01) in control, deficient and excess groups, respectively.
|
We performed Western blot analysis with cardiac membranes using RM-1,
an antibody specific to
subunit of Gs, to compare the Gs content of
the membranes from all three groups. Gs antibody identified two
membrane protein bands in all membranes; one with the apparent
molecular mass of 45 KD and the other 52 KD. Both of these bands
appeared to be the same in all three groups (Fig. 5
).
|
| DISCUSSION |
|---|
|
|
|---|
content of the membranes, on the other hand, was similar
in all groups.
We have previously shown that in rats, altering the Se content (along
with vitamin E) of the diet causes a diminished ß-adrenergic response
in electrically stimulated papillary muscle preparations. The muscles
from rats fed a Se- and vitamin E-deficient or a Se-excess diet
showed a significantly lower maximum response to ISO. The electrically
driven contractions in the absence of ISO (i.e., basal contractions),
however, were observed to be the same for control and experimental
groups (Turan et al. 1999
). This observation may suggest
that Se deficiency or excess does not interfere directly with the
contractile machinery itself, but instead affects the signal
transduction pathway of the ß-adrenoceptors (including adrenoceptors,
G-proteins, adenylate cyclase (AC), protein kinase A (PKA) and
Ca-channel) present in the cardiac tissue and thus depress the ISO
response.
It should be noted that although T-type Ca2+ channels are absent in adult rat cardiac myocytes and the TTX concentration used in this study blocks Na+ currents effectively, the apparent change in the ICa,L threshold potential for activation may be due to emergence of T-type Ca2+ channels or to alteration of Na+ channel activity induced by the changes in the diet. This point requires further study to clarify.
The present results indicate an alteration in the signaling
pathway of ß-adrenoceptors in the deficient rats. First of all, the
total ß-adrenoceptor number on the cardiac membranes of these animals
appeared to be about 30% lower than the control rats. Secondly, ISO
inducible AC activity was decreased, and finally the GppNHp-induced
shift in apparent agonist affinity disappeared. Although in the
deficient group, GppNHp-induced AC activity was similar to that
obtained in the control group, forskolin-induced activity was less.
A straightforward interpretation of the latter result can be a decrease
in the number of AC molecules in the membrane. However, this
interpretation is inconsistent with the fact that GppNHp can induce
full cyclase activity in the deficient group. Another explanation can
then be a reduced coupling between Gs and ß-adrenoceptor. This
interpretation is consistent with the decrease in GppNHp-induced
shift in apparent agonist affinity seen in these membranes. Such an
interpretation is actually consistent with the whole picture obtained
in the Se-deficient group: i) As has been shown in the experiments
with negative antagonists, the spontaneous coupling between receptor
and Gs contributes, at a certain extent, to basal cyclase activity
(Lefkowitz et al. 1993
), which is also the case for the
present membrane preparations (data not shown). Thus, a reduction in
receptor-Gs coupling is expected to result in a decrease in the
basal cyclase activity, ii) A reduced basal coupling between receptor
and Gs also explains the reduction in forskolin-induced cyclase
activity observed in deficient group membranes, when we consider the
allosteric nature of the interaction between ß-adrenoceptor, Gs, AC
and forskolin. It has been suggested that the interaction of Gs with
cyclase is required for forskolin to work on AC (Seamon and Daly 1986
). Hence, reduction in spontaneous Gs activation by
ß-adrenoceptor may reduce the spontaneous coupling between cyclase
and Gs, and thus decrease forskolin-induced cyclase activity, iii)
Reduced coupling of ß-adrenoceptor and Gs may obviously lead to an
impairment of isoproterenol-induced cyclase activity and finally,
iv) GppNHp-induced activation of cyclase should be insensitive to
the reduction of receptor-Gs coupling, which was experimentally the
case for the deficient group. All the four points fit well with the
present observations in the deficient group.
In conclusion, in the heart, the effect of Se and vitamin E deficiency on ß-adrenoceptor and AC system is two-fold: i) there is a decrease in ß-adrenoceptor number, which, however does not seem to explain all results obtained in deficient group and ii) Coupling between ß-adrenoceptor and Gs is decreased. The reduced coupling does not appear to be due to a lowered Gs number, because Western blots of the cardiac membranes showed no appreciable change in the amount of Gs.
On the other hand, in the excess group we did not find any differences in the ß-adrenoceptor-AC system. All the variables we investigated appeared to be similar to those in the control rats. For an explanation of the effect of Se excess on the contractile response to ISO, we should consider a mechanism which is distal to the AC.
In cardiac cells, ß-adrenergic agonists increase cAMP production through stimulation of AC via Gs. Cyclic-AMP in turn activates PKA which modulates Ca-channels in these cells. Calcium channels and PKA can be the points, distal to the AC, where Se excess may have an effect and decrease the ISO responses in the hearts of the excess group. Interestingly, the effect of ISO on the calcium current was also smaller in both deficient and excess group cells. Although this reduction in the deficient group cell response can be explained by a diminished transduction in ß-adrenoceptor and AC system, such an explanation does not appear to be likely in excess group cells. To understand the reduction in excess group cells, two possible explanations can be put forth: i) a change in the Ca-channel itself, induced by Se excess, which renders it resistant to modulation by PKA or ii) a pathology in PKA itself which reduces its activity. Observed change in the kinetics of the ICa,L may indicate such an alteration in the channel protein or PKA. It should be emphasized that the possibility of a similar alteration in the Ca-channel and/or PKA function cannot be excluded for deficient group cells and requires further investigation.
Our findings indicate a change in basal and ISO stimulated activity of cardiac ICa,L in rats fed either Se-excess or Se- and vitamin E-deficient diet. In addition to these changes in cardiac currents, ß-adrenergic signal transduction machinery seems to be compromised in rats fed the deficient diet. These findings can be helpful not only in understanding cardiac pathologies related to Se- and vitamin E-deficiency and Se toxicity, but they can also help to clarify the role of Se in the physiology of the heart and the processes where it might be involved.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
3 Abbreviations used: AC, adenylate cyclase; GppNHp, 5' guanylyimidodphosphate; PKA, protein kinase A; ISO,
isoproterenol; IcaL, L type calcium current;
[125I]-IPIN, [125I]-iodopindolol. ![]()
Manuscript received July 29, 1999. Initial review completed September 15, 1999. Revision accepted December 13, 1999.
| REFERENCES |
|---|
|
|
|---|
1. Anundi I., Hogberg J., Stahl A. Involvement of glutathione reductase in selenite metabolism and toxicity, studied in isolated rat hepatocytes. Arch. Toxicol. 1982;50:113-123[Medline]
2. Barovsky K., Brooker G. (-)-[125I]-iodopindolol, a new highly selective radioiodinated beta-adrenergic receptor antagonist: measurement of beta-receptors on intact rat astrocytoma cells. J. Cyclic Nucleotide Res. 1980;6:297-307[Medline]
3.
Berly E. J., Gillian L. Direct determination of selenium of graphite furnace atomic absorption spectrometry with deuterium background correction and a reduced palladium modifier: age specific reference changes. Clin. Chem. 1988;34:709-714
4. Bettger W. J. Zinc and selenium, site-specific versus general antioxidation. Can. J. Physiol. Pharmacol. 1993;71:721-724[Medline]
5.
Björnstedt M., Kumar S., Holmgren A. Selenodiglutathione is a highly efficient oxidant of reduced thioredoxin and substrate for mammalian thioredoxin reductase. J. Biol. Chem. 1992;267:8030-8034
6. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Annal. Biochem. 1976;72:248-254[Medline]
7. Burk R. F. Recent developments in trace element metabolism and function: newer roles of selenium in nutrition. J. Nutr. 1989;119:1051-1054
8. Burk R. F. Protection against free radical injury by selenoenzymes. Pharmacol. Ther. 1990;45:383-385[Medline]
9. Chen X., Yang G., Chan J., Chen X., Wen Z., Ge K. Studies on the relationships of selenium and Keshan disease. Biol. Trace Element Res. 1980;2:91-107
10. De Lean A., Munson P. J., Rodbard D. Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand, and physiological dose-response curves. Am. J. Physiol. 1978;253:E97-E102
11. Dickson R. C., Tappel A. L. Reduction of selenocystine by cysteine or glutathione. Arch. Biochem. Biophysic. 1969;130:547-550
12. Frenkel G. D., Falvey D., MacVicar C. Products of the reaction of selenite with intracellular sulfhydryl compounds. Biol. Trace Elem. Res. 1991;30:9-18[Medline]
13. Grupp I. L., Jamall I. S., Millard R. W., Grupp G. Effects of dietary selenium deficiency and selenium and calcium supplementation on myocardial contractile force and oubain sensitivity of the rat heart. IRCS Med. Sci. 1983;11:22-23
14.
Handel M. L., Watts C .K. W., DeFazio A., Day R. O. Inhibition of AP-1 binding and transcription by gold and selenium involving conserved cysteine residues in Jun and Fos. Proc. Natl. Acad. Sci. USA 1995;92:4497-4501
15.
Hightower K. R., McCready J. P. Effects of selenite on epithelium of cultured rabbit lens. Invest. Ophthalmol. Vis. Sci. 1991;32:406-409
16. Hoekstra W. G. Biochemical function of selenium and its relation to vitamin E. Federation Proc 1975;34:2083-2089[Medline]
17. Koukay N., Mouhineddine S., Richard M. J., Arnaud J., DeLeiris J., Favier A. Influence of selenium on lipid peroxidation and cardiac functions in chronically adriamycin-treated rats. Emerit I. Packer L. Auclair C. eds. Antioxidants in Therapy and Preventive Medicine Advances in Experimental Medicine and Biology 1990;264:353-359 Plenum Press New York.
18. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.) 1970;229:680-685
19. Lefkowitz R. J., Cotecchia S., Samama P., Costa T. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol. Sci. 1993;14:303-307[Medline]
20. Leibovitz B., Hu M. L., Tappel A. L. Dietary supplements of vitamin E, ß-carotene-coenzyme Q10, and selenium protect tissues against lipid peroxidation in rat tissue slices. J. Nutr. 1990;120:97-104
21. Levander O. A. Selenium. Mertz W. eds. Trace Elements in Human and Animal Nutrition 1986:209-279 Academic Press New York, NY.
22. Li G. S., Wang F., Kang D. R., Li C. Keshan disease: an endemic cardiomyopathy in China. Human Pathol 1985;16:602-609[Medline]
23. Lin-Shiau S. Y., Liu S. H., Fu W. M. Studies on the contracture of the mouse diaphragm induced by sodium selenite. Eur. J. Pharmacol. 1989;167:137-146[Medline]
24.
McMurray C. H., Blanchflower W. J. Application of a high performance liquid chromatographic fluorescence method for the rapid determination of
-tocopherol in the plasma of cattle and pigs and its comparison with direct fluorescence and high performance liquid chromatography-ultraviolet detection methods. J. Chromatogr. 1979;178:525-531[Medline]
25. Neve J. Physiological and nutritional importance of selenium. Experinetia 1991;47:187-193
26. Oldfield J. E. The two faces of selenium. J. Nutr. 1987;117:2002-2008
27. Olson J. A., Kobayoshi S. Antioxidants in health and disease: overview. Proc. Soc. Exp. Biol. Med. 1992;200:245-247[Medline]
28. Poltronieri R., Cevese A., Sbartani A. Protective effect of selenium in cardiac ischemia and reperfusion. Cardioscience 1992;3:155-160[Medline]
29. Ringstad J., Tande P. M., Norheim G., Refsum H. Selenium deficiency and cardiac electrophysiological and mechanical function in the rat. Pharmacol. Toxicol. 1988;63:189-192[Medline]
30. Salonen J. T., Salonen R., Pentila I., Herranen J., Tauhiainen M., Kantola S., Lappetelainen R., Maenpaa P., Alfthan G., Puska P. Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. Am. J. Cardiol. 1985;56:226-231[Medline]
31. Salonen J. T., Salonen R., Seppanen K., Kantola S., Parviainen M., Alfthan G., Maenpaa P. Relationship of serum selenium and antioxidants to plasma lipoproteins, platelet aggreability and prevalent ischaemic heart disease in Eastrean Finnish men. Atherosclerosis 1988;70:155-160[Medline]
32. Schwarz K. Role of vitamin E, selenium and related factors in experimental nutritional liver diseases. Federation Proc 1965;24:58-62
33. Seamon K. B., Daly J. W. Forskolin: Its biological and chemical properties. Adv. Cyclic Nucl. Protein Phosphoryl. Res. 1986;20:1-150[Medline]
34. Shamberger R. J. Selenium Deficiency Diseases in Animals. Biochemistry of Selenium 1983:31-58 Plenum Press New York, NY.
35. Sunde R. A. Molecular biology of selenoproteins. Annu. Rev. Nutr. 1990;10:451-474[Medline]
36. Sword J. T., Pope A. I., Hoekstra W. G. Endotoxin and lipid peroxidation in vitro in selenium- and vitaminE-deficient and adequate rat tissues. J. Nutr. 1991;121:258-264
37. Tappel A. L. Free radical lipid peroxidation damage and its inhibition by vitamin E and selenium. Federation Proc 1965;24:73-79
38.
Tsen C. C., Tappel A. L. Catalytic oxidation of glutathione and other sulfhydryl compounds by selenite. J. Biol. Chem. 1958;233:1230-1232
39.
Turan B., Desilets M., Acan L. N., Hotomaroglu Ö, Vannier C., Vassort G. Oxidative effects of selenite on rat ventricular contractility and Ca movements. Cardiovasc.Res. 1996;32:351-361
40. Turan B., Hotomaroglu O., Kilic M., Demirel-Yilmaz E. Cardiac dysfunction induced by low and high diet antioxidant levels comparing selenium and vitamin E in rats. Regulatory Tox. Pharmacol. 1999;29:142-150
41. Ugur O., Onaran H. O. Allosteric equilibrium model explains steady-state coupling of beta-adrenergic receptors to adenylate cyclase in turkey erythrocyte membranes. Biochem. J. 1997;323:765-776
42. Wang Z., Bunce G. E., Hess J. L. Selenite and Ca2+ homeostasis in the rat lens: effect on Ca-ATPase and passive Ca2+ transport. Curr. Eye Res. 1993;12:2213-2218
43.
Wittenberg B. A., White R. L., Ginzberg R. D., Spray D. C. Effect of calcium on the dissociation of the mature rat heart into individual and paired myocytes: Electrical properties of cell pairs. Circ. Res. 1986;59:143-150
44. Wolf B. B., Harden T. K. Guanine nucleotides modulate the affinity of antagonists at beta-adrenergic receptor. J. Cyclic Nucleotide Res. 1981;7:303-312[Medline]
45.
Yang G., Wang S., Zhou R., Sun S. Endemic selenium intoxication of humans in China. Am. J. Clin. Nutr. 1983;37:872-881
46. Yang F. Y., Yang M. Z. Reaction of Se with SH groups in spectrin is involved in the stabilization of erytrocyte membrane skeleton. Biochem. Int. 1989;18:1085-1091[Medline]
47. Young J. D., Crowley C, Tucker E. M. Heamolysis of normal and glutathione-deficient sheep erythrocytes by selenite and tellurite. Biochem. Pharmacol. 1981;30:2527-2530[Medline]
48. Ytreus K., Ringstad J., Myklebust R., Norheim G., Mjos O. D. The selenium-deficient rat heart with special reference to tolerance against enzymatically generated oxygen radicals. Scand. J. Clin. Lab. Invest. 1988;48:289-295[Medline]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||